229 related articles for article (PubMed ID: 36118894)
1. T cell proliferation-related genes: Predicting prognosis, identifying the cold and hot tumors, and guiding treatment in clear cell renal cell carcinoma.
Huang H; Cai Y; Hong X; Gao W; Tang J; Zhang S; Xu Z
Front Genet; 2022; 13():948734. PubMed ID: 36118894
[No Abstract] [Full Text] [Related]
2. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
Chen Y; He J; Jin T; Zhang Y; Ou Y
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
[TBL] [Abstract][Full Text] [Related]
3. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs.
Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H
Front Immunol; 2022; 13():916800. PubMed ID: 35860239
[TBL] [Abstract][Full Text] [Related]
4. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma.
Huang Y; Guo W; Zeng Y; Wang X; Fan B; Zhang Y; Yan L; Gu G; Liu Z
Front Oncol; 2024; 14():1354049. PubMed ID: 38454924
[TBL] [Abstract][Full Text] [Related]
6. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
Zhou Q; Sun Q; Shen Q; Li X; Qian J
Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
Front Immunol; 2022; 13():934243. PubMed ID: 36189255
[TBL] [Abstract][Full Text] [Related]
8. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of necroptosis-related long noncoding RNA to predict prognosis, immune status, and immunotherapeutic response in clear cell renal cell carcinoma.
Tang H; Chen H; Yuan H; Jin X; Chen G
Transl Cancer Res; 2022 Dec; 11(12):4254-4271. PubMed ID: 36644185
[TBL] [Abstract][Full Text] [Related]
10. Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma.
Pan H; Lu W; Zhang M; Liu C
Front Oncol; 2023; 13():1131191. PubMed ID: 37182129
[TBL] [Abstract][Full Text] [Related]
11. Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs.
Hao C; Li R; Lu Z; He K; Shen J; Wang T; Qiu T
Front Immunol; 2023; 14():1145450. PubMed ID: 37359524
[TBL] [Abstract][Full Text] [Related]
12. A promising natural killer cell-based model and a nomogram for the prognostic prediction of clear-cell renal cell carcinoma.
Yao Q; Zhang X; Wang Y; Wang C; Chen J; Chen D
Eur J Med Res; 2024 Jan; 29(1):73. PubMed ID: 38268058
[TBL] [Abstract][Full Text] [Related]
13. Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer.
Zhao Z; Liu H; Zhou X; Fang D; Ou X; Ye J; Peng J; Xu J
J Oncol; 2021; 2021():6718443. PubMed ID: 34790235
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
Li W; Ling L; Xiang L; Ding P; Yue W
Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
[TBL] [Abstract][Full Text] [Related]
15. Construction and validation of a prognostic model for predicting clear cell renal cell carcinoma based on complement-related genes.
Qian C; Sun Y; Di S; Wang H; Tian Y; Wang C; Cui X
Transl Androl Urol; 2023 Apr; 12(4):659-672. PubMed ID: 37181236
[TBL] [Abstract][Full Text] [Related]
16. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
[TBL] [Abstract][Full Text] [Related]
17. A Ferroptosis-Related Genes Model Allows for Prognosis and Treatment Stratification of Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis and Experimental Verification.
Wu J; Sun Z; Bi Q; Wang W
Front Oncol; 2022; 12():815223. PubMed ID: 35155251
[TBL] [Abstract][Full Text] [Related]
18. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
19. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
Front Genet; 2022; 13():905051. PubMed ID: 35846134
[TBL] [Abstract][Full Text] [Related]
20. A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.
Zhou T; Chen W; Wu Z; Cai J; Zhou C
Front Genet; 2022; 13():994208. PubMed ID: 36186476
[No Abstract] [Full Text] [Related]
[Next] [New Search]